Abstract
Due to the increasing availability of monoclonal antibodies (MAbs) recognizing lymphoid-, myeloid-, and progenitor-cell-associated antigens, immunophenotyping has greatly influenced studies on the biologic features of normal and leukemic hematopoietic progenitor cells (Greaves 1986). It has become possible to demonstrate the practical value of these data for the precise diagnosis and definition of clinically relevant immunophenotypic subsets of acute lymphoblastic leukemia (ALL) (Janossy et al. 1989). More recently, immunophenotyping has been supplemented by cytogenetic and molecular-genetic analyses in order to better characterize the biologic heterogeneity of ALL and to elucidate the mechanisms of lymphoid cell transformation and aberrant regulation of leukemic cell growth (Look 1988; Bain and Catovsky 1990; Pui et al. 1990c; van Dongen and Wolvers-Tettero 1991).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bain B, Catovsky D (1990) Current concerns in haematology 2: classification of acute leukaemia. J Clin Pathol 43: 882–887
Béné MC, Boumsell L, Vannier JP, Garand R, Solary E, Faure G, Bernard A, French Groupe d’Etude Immunologique des Leucémies (GEIL) (1989) Immunologic analysis of a thousand cases of acute leukemia. Nouv Rev Fr Hematol 31: 133–136
Bleyer WA (1990) Acute lymphoblastic leukemia in children. Advances and pro-spectus. Cancer 65: 689–695
Borowitz MJ, Shuster JJ, Civin CI, Carroll AJ, Look AT, Behm FG, Land VJ, Pullen DJ, Crist WM (1990) Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study. J Clin Oncol 8: 1389–1398
Borowitz MJ, Shuster JJ, Land VJ, Steuber CP, Pullen DJ, Vietti T (1991) Myeloid-antigen expression in childhood acute lymphoblastic leukemia. N Engl J Med 325: 1379–1380
Brown L, Cheng JT, Chen Q, Siciliano MJ, Crist W, Buchanan G, Baer R (1990) Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J 9: 3343–3351
Cantù-Rajnoldi A, Putti C, Saitta M, Granchi D, Foà R, Schirô R, Castagni M, Valeggio C, Jankovic M, Miniero R, Paolucci P, Basso G (1991) Co-expression of myeloid antigens in childhood acute lymphoblastic leukaemia: relationship with the stage of differentiation and clinical significance. Br J Haematol 79: 40 - 43
Chessells JM, Hardisty RM, Richards S (1987) Long survival in childhood lymphoblastic leukemia. Br J Cancer 55: 315 — 319
Crist WM, Shuster JJ, Falletta J, Pullen DJ, Berard CW, Vietti TJ, Alvarado CS, Roper MA, Prasthofer E, Grossi CE (1988) Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study. Blood 72: 1891–1897
Crist W, Boyett J, Jackson J, Vietti T, Borowitz M, Chauvenet A, Winick N, Ragab A, Mahoney D, Head D, Iyer R, Wagner H, Pullen J (1989) Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 74: 1252–1259
Crist WM, Carroll AJ, Shuster JJ, Behm FG, Whitehead M, Vietti TJ, Look AT, Mahoney D, Ragab A, Pullen DJ, Land VJ (1990) Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood 76: 117–122
Drexler HG, Thiel E, Ludwig WD (1991) Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 5: 637–645
Fletcher JA, Kimball VM, Lynch E, Donnelly M, Pavelka K, Gelber RD, Tantravahi R, Salla SE (1989) Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia. Blood 74: 2130–2135
Garand R, Vannier JP, Béné MC, Faure G, Favre M, Bernard A, Groupe d’Etude Immunologique des Leucémies (1990) Comparison of outcome, clinical, laboratory, and immunological features in 164 children and adults with T-ALL. Leukemia 4: 739–744
Greaves MF (1986) Differentiation-linked leukemogenesis in lymphocytes. Science 234: 697–704
Janossy G, Coustan-Smith E, Campana D (1989) The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Leukemia 3: 170–181
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481
Katz F, Malcolm S, Gibbons B, Tilly R, Lam G, Robertson ME, Czepulkowski B, Chessells J (1988) Cellular and molecular studies on infant null acute lymphoblastic leukemia. Blood 71: 1438–1447
Look AT (1988) The cytogenetics of childhood leukemia: clinical and biologic implications. Pediatr Clin North Am 35: 723–741
Ludwig WD, Bartram CR, Ritter J, Raghavachar A, Hiddemann W, Heil G, Harbott J, Seibt-Jung H, Teichmann JV, Riehm H (1988) Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood 71: 1518–1528
Ludwig WD, Bartram CR, Harbott J, Koller U, Haas OA, Hansen-Hagge T, Heil G, Seibt-Jung H, Teichmann JV, Ritter J, Knapp W, Gadner H, Thiel E, Riehm J (1989a) Phenotypic and genotypic heterogeneity in infant acute leukemia: I. Acute lymphoblastic leukemia. Leukemia 3: 431–439
Ludwig WD, Seibt-Jung H, Teichmann JV, Komischke B, Gatzke A, Gassner G, Odenwald E, Hofmann J, Riehm H (1989b) Clinicopathological features and prognostic implications of immunophenotypic subgroups in childhood ALL: experience of the BFM-ALL study 83. In: Neth R, Gallo RC, Greaves MF, Gaedicke G, Gohla S, Mannweiler K, Ritter J (eds) Modern trends in human leukemia VIII. Springer, Berlin Heidelberg New York, pp 51–57 (Haematology and blood transfusion, vol 32 )
Ludwig WD, Bartram CR, Raghavachar A, Harbott J, Thiel E, Riehm H (1990a) Clinical relevance of immunoglobulin (Ig) and T-cell receptor (TCR) gene re-arrangements in childhood B-cell precursor (BCP)-ALL. Blood 76 [Suppl 1]: 298a
Ludwig WD, Thiel E, Bartram CR, Kranz BR, Raghavachar A, Löffler H, Ganser A, Büchner T, Hiddemann W, Heil G, Freund M, Maschmeyer G, Reiter A, Messerer D, Riehm H, Hoelzer D (1990b) Clinical importance of T-ALL sub-classification according to thymic or prethymic maturation stage. In: Büchner T, Schellong G, Hiddemann W, Ritter J (eds) Acute Leukemias: II. Prognostic factors and treatment strategies. Springer, Berlin Heidelberg New York, pp 419–247 (Haematology and blood transfusion, vol 33 )
Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163–170
O’Connor R, Cesano A, Lange B, Finan J, Nowell PC, Clark SC, Raimondi SC, Rovera G, Santoli D (1991) Growth factor requirements of childhood acute T- lymphoblastic leukemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro. Blood 77: 1534–1545
Pui CH, Williams DL, Raimondi SC, Melvin SL, Behm FG, Look AT, Dahl GV, Rivera GK, Kalwinsky DK, Mirro J, Dodge RK, Murphy SB (1986) Unfavorable presenting clinical and laboratory features are associated with CALLA-negative non-T, non-B lymphoblastic leukemia in children. Leuk Res 10: 1287–1292
Pui CH, Behm FG, Singh B, Rivera GK, Schell MJ, Roberts WM, Crist WM, Mirro J (1990a) Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 75: 198–202
Pui CH, Behm FG, Singh B, Schell MJ, Williams DL, Rivera GK, Kalwinsky DK, Sandlund JT, Crist WM, Raimondi SC (1990b) Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood 75: 174–179
Pui CH, Crist WM, Look AT (1990c) Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 76: 1449–1463
Pui CH, Frankel LS, Carroll AJ, Raimondi SC, Shuster JJ, Head DR, Crist WM, Land VJ, Pullen J, Steuber CP, Behm FG, Borowitz MJ (1991a) Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. Blood 77: 440–447
Pui CH, Raimondi SC, Head DR, Schell MJ, Rivera GK, Mirro J, Crist WM, Behm FG (1991b) Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 78: 1327–1337
Raimondi SC, Behm FG, Roberson PK, Pui CH, Rivera GK, Murphy SB, Williams DL (1988) Cytogenetics of childhood T-cell leukemia. Blood 72: 1560–1566
Raimondi SC, Behm FG, Roberson PK, Williams DL, Pui CH, Crist WM, Look AT, Rivera GK (1990) Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol 8: 1380–1388
Riehm H, Gadner H, Henze G, Kornhuber B, Lampert F, Niethammer D, Reiter A, Schellong G (1990) Results and significance of six randomized trials in four consecutive ALL-BFM studies. In: Büchner T, Schellong G, Hiddemann W, Ritter J (eds) Acute Leukemias: II. Prognostic factors and treatment strategies. Springer, Berlin Heidelberg New York, pp 439–450 (Haematology and blood transfusion, vol 33 )
Sawyers CL, Denny CT, Witte ON (1991) Leukemia and the disruption of normal hematopoiesis. Cell 64: 337–350
Shuster JJ, Falletta JM, Pullen DJ, Crist WM, Humphrey GB, Dowell BL, Wharam MD, Borowitz M (1990) Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 75: 166–173
Thiel E, Kranz BR, Raghavachar A, Bartram CR, Löffler H, Messerer D, Ganser A, Ludwig WD, Büchner T, Hoelzer (1989) Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood 73: 1247–1258
Van der Does-van den Berg A, Bartram CR, Basso G, Benoit Y, Biondi A, Debatin K, Haas O, Harbott J, Kamps WA, Koller U, Lampert F, Ludwig WD, Niemeyer C, van Wering ER (1992) Minimal requirements for the diagnosis, classification and evaluation of the treatment of childhood acute lymphoblastic leukemia ( ALL) in the “BFM family” cooperative group. Med Pediatr Oncol 20: 497–505
Van Dongen JJM, Wolvers-Tettero ILM (1991) Analysis of immunoglobulin and T cell receptor genes: II. Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta 198: 93–171
Wiersma SR, Ortega J, Sobel E, Weinberg KI (1991) Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med 324: 800–808
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Ludwig, WD. et al. (1993). Incidence and Prognostic Significance of Immunophenotypic Subgroups in Childhood Acute Lymphoblastic Leukemia: Experience of the BFM Study 86. In: Ludwig, WD., Thiel, E. (eds) Recent Advances in Cell Biology of Acute Leukemia. Recent Results in Cancer Research, vol 131. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84895-7_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-84895-7_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84897-1
Online ISBN: 978-3-642-84895-7
eBook Packages: Springer Book Archive